Epogen
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
e13158 Background: The use of erythropoiesis-stimulating agents (ESAs) for the treatment of anemia in cancer patients underwent a…
Přehledný clanek se věnuje problematice systemů řizeni rizik leciv – akcnim planům minimalizovani rizika (RiskMAPs), strategii…
IS ANEMIA TO BLAME? A common cause of fatigue, asthenia, and weakness among patients coping with cancer, anemia may be a result…
NEW DRUGS Lapatinib (Tykerb) For Advanced Breast Cancer The Food and Drug Administration (FDA) has approved lapatinib (Tykerb…
Last month, the House Ways and Means Committee held a hearing on patient safety and quality issues regarding end-stage renal…
Carnitor use for carnitine deficiency in chronic renal failure is a multidisciplinary management issue. This medication and its…
The purpose of this project was to determine a safe and effective Epogen (EPO) subcutaneous administration schedule for patients…
PROCRIT is an exogenous form of erythropoietin now marketed for use in anemic predialysis patients and AZT-treated HIV-positive…
This article presents a nursing care plan and patient education plan for patients receiving recombinant human erythropoietin in…